Evidence map›Paper›PMID 36820214›Full record

ArticleCase reports in oncology

Mandibular Metastasis as the First Manifestation of Hepatocellular Carcinoma: A Case Report.

Ricardo Fernández-Ferreira, Roberto Savage-Leyva, Luis Fernando Durán-Guerrero, Maria Del Rocio Carranza-Sevilla, Carlos Zamorano-Vazquez, Carlos-Emmanuel Florencio Monroy-Godínez, Germán-Raymundo Hernández-Ramírez, Jose Manuel Torres-Zazueta, Ernesto Ceron-Ibarra, Rita Dorantes-Heredia

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ricardo Fernández-FerreiraInternal Medicine Department, Tula PEMEX General Hospital, Tula, Mexico.
Roberto Savage-LeyvaInternal and Oncology Medicine Department, Tula General Hospital, Tula, Mexico.
Luis Fernando Durán-GuerreroInternal Medicine Department, Tula PEMEX General Hospital, Tula, Mexico.
Maria Del Rocio Carranza-SevillaInternal Medicine Department, Tula PEMEX General Hospital, Tula, Mexico.
Carlos Zamorano-VazquezInternal and Oncology Medicine Department, Tula General Hospital, Tula, Mexico.
Carlos-Emmanuel Florencio Monroy-GodínezInternal and Oncology Medicine Department, Tula General Hospital, Tula, Mexico.
Germán-Raymundo Hernández-RamírezInternal and Oncology Medicine Department, Tula General Hospital, Tula, Mexico.
Jose Manuel Torres-ZazuetaOncology Medicine Department, Comprehensive Oncology Center "Diana Laura Riojas de Colosio", Medica Sur Hospital, Mexico City, Mexico.
Ernesto Ceron-IbarraInternal and Oncology Medicine Department, Tula General Hospital, Tula, Mexico.
Rita Dorantes-HerediaService of Anatomical Pathology, Medica Sur Hospital, Mexico City, Mexico.
Pemex (Mexico) · MXHospital Médica Sur · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic malignancies of the oral cavity are rare lesions, accounting for only 1-4% of all oral malignancies, and can occur in the jaw bones, the oral soft tissues, or even both. Although hepatocellular carcinoma is the most common primary hepatic tumor, no more than 1% of the cases show oral involvement. When metastatic tumor involves the oral cavity, the most frequent site is the posterior angle of the mandible. Histologically, hence, immunohistochemical markers are used for diagnosis. Glypican-3 and HepPar1 are the markers that can be used to confirm the microscopic diagnosis of HCC. Very rarely, hepatocellular carcinoma (HCC) metastasizes to the oral cavity, and such cases have a poor prognosis due to delay in diagnosis. We present a 74-year-old male with a metastasis of HCC in the left mandibular body as the first manifestation. Histologic examination confirmed metastatic hepatocellular carcinoma in the oral mucosa with immunohistochemical (IHC) markers. A review of pertinent literature was performed. Given the rarity of the disease, treatment principles are based mainly on retrospective series and case reports. We report an exceptionally unusual presentation with few cases (<70) reported in the literature, thus representing a diagnostic challenge.

Indexed as

Diagnostic challengeHepatocellular carcinomaImmunohistochemical markersMetastatic malignancies

Identifiers

PMID36820214
PMCPMC9938403
OpenAlexW4321181007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.